Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$190M |
| 2 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$178M |
| 3 |
Meta Platforms (Facebook)
META
|
+$172M |
| 4 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$169M |
| 5 |
Microsoft
MSFT
|
+$166M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$278M |
| 2 |
Intel
INTC
|
+$223M |
| 3 |
PPLI
People Inc
PPLI
|
+$210M |
| 4 |
Mastercard
MA
|
+$210M |
| 5 |
Honeywell
HON
|
+$188M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.18% |
| 2 | Consumer Discretionary | 6.93% |
| 3 | Technology | 6.31% |
| 4 | Industrials | 5.82% |
| 5 | Financials | 5.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATXS
4201
DELISTED
Astria Therapeutics
ATXS
| $78 | ﹤0.01% |
2,096
-675
| -24% | -$26.7K |
|
4202
ADMA Biologics
ADMA
$2.14B
| $76 | ﹤0.01% |
31,747
-291,080
| -90% | -$798K |
|
|
OIIM
4203
DELISTED
02Micro International
OIIM
| $76 | ﹤0.01% |
+21,603
| New | +$57.9K |
|
|
ATRS
4204
DELISTED
Antares Pharma, Inc.
ATRS
| $76 | ﹤0.01% |
28,140
-463,834
| -94% | -$1.28M |
|
|
SECO
4205
DELISTED
Secoo Holding Limited ADR
SECO
| $75 | ﹤0.01% |
2,811
-10,777
| -79% | -$296K |
|
4206
Hallador Energy
HNRG
$752M
| $74 | ﹤0.01% |
113,258
+33,286
| +42% | +$24.1K |
|
|
ATYR
4207
aTyr Pharma
ATYR
$51.2M
| $74 | ﹤0.01% |
+22,771
| New | +$93.5K |
|
|
CLPR
4208
Clipper Realty
CLPR
$55.3M
| $72 | ﹤0.01% |
11,904
-6,208
| -34% | -$42K |
|
4209
DHI Group
DHX
$183M
| $72 | ﹤0.01% |
31,648
-55,629
| -64% | -$138K |
|
|
OXLC
4210
Oxford Lane Capital
OXLC
$931M
| $72 | ﹤0.01% |
+3,268
| New | +$70K |
|
4211
Tiziana Life Sciences
TLSA
$148M
| $72 | ﹤0.01% |
+21,380
| New | +$83.2K |
|
4212
Full House Resorts
FLL
$78.4M
| $71 | ﹤0.01% |
+36,783
| New | +$63.5K |
|
4213
Jerash Holdings
JRSH
$71.5M
| $71 | ﹤0.01% |
15,555
-7,246
| -32% | -$34K |
|
|
SMM
4214
DELISTED
Salient Midstream & MLP Fund
SMM
| $71 | ﹤0.01% |
+20,209
| New | +$80.4K |
|
|
NWHM
4215
DELISTED
THE NEW HOME COMPANY INC.
NWHM
| $71 | ﹤0.01% |
13,014
-49,352
| -79% | -$202K |
|
|
NAAS
4216
NaaS Technology Inc
NAAS
$55.9M
| $70 | ﹤0.01% |
1
-3
| -75% | -$114K |
|
|
YARW
4217
Yarrow Bioscience
YARW
$106M
| $70 | ﹤0.01% |
12
-369
| -97% | -$2.15M |
|
|
PHX
4218
DELISTED
PHX Minerals
PHX
| $69 | ﹤0.01% |
48,189
-51,153
| -51% | -$110K |
|
|
CSLT
4219
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $69 | ﹤0.01% |
61,370
-185,239
| -75% | -$204K |
|
4220
Itaú Unibanco
ITUB
$82.8B
| $68 | ﹤0.01% |
23,457
-2,456,862
| -99% | -$8.34M |
|
4221
Tonix Pharmaceuticals
TNXP
$213M
| – | – |
0
| – | – |
|
|
VRNA
4222
DELISTED
Verona Pharma
VRNA
| $68 | ﹤0.01% |
+10,942
| New | +$75.6K |
|
|
FAX
4223
abrdn Asia-Pacific Income Fund
FAX
$599M
| $66 | ﹤0.01% |
2,754
-28,751
| -91% | -$693K |
|
4224
Civeo
CVEO
$348M
| $64 | ﹤0.01% |
7,873
+5,990
| +318% | +$53.6K |
|
|
ACGN
4225
CALL
DELISTED
Aceragen Inc
ACGN
| $64 | ﹤0.01% |
+1,766
| New | +$62.7K |
|
Similar funds
Israel Englander's Q3 2020 Portfolio in Review
As of Q3 2020, Israel Englander held 5,106 positions worth $81.2M, down 100% from $73B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $869M of net new capital in Q3 2020, opening 989 new positions and adding to 1,503 existing holdings. Its largest new stake was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
By sector, the portfolio is most concentrated in Healthcare at 9.2% of assets, up from 9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was JPMorgan Chase, an estimated $278M trimmed.
- Israel Englander's largest Q3 2020 buy was Pershing Square Tontine Holdings, Ltd.: 5,275,934 shares worth $120K.
- Israel Englander added most to Varian Medical Systems, Inc. in Q3 2020, an estimated $190M increase.
- Israel Englander's biggest Q3 2020 reduction was JPMorgan Chase, cutting an estimated $278M.
- Israel Englander fully exited Tech Data Corp in Q3 2020, selling an estimated $186M.
- Israel Englander's ten largest holdings make up 18% of its $81.2M portfolio in Q3 2020.
- Israel Englander opened 989 new positions and closed 724 in Q3 2020.
- Israel Englander's portfolio value fell 100% quarter-over-quarter to $81.2M.
Based on Millennium Management's 13F filing for Q3 2020, filed 16 Nov 2020.